The Valley Desk

NCT02604433 · Interventional trial

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia

Overall registry status Completed

Phase 3

Conditions Beta-Thalassemia, Erythrocyte Transfusion

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov